EY Client Portal Library About us Newsroom Connect with us United States (English) Home Insights Industries Services Careers Alumni Home > Industries > Life Sciences HIMSS17: Mind the gap We explore takeaways from the 2017 Healthcare Information and Management Systems Society conference, including data, AI, digital and women in healthcare IT. HIMSS17: Mind the gap It’s time to bring drug pricing down The 2017 outlook for life sciences Life Sciences Overview About our Life Sciences services Advisory Assurance Tax Transactions Library Contacts Press Events The need for alignment to achieve health outcomes for all As populations age and chronic diseases become commonplace, health care will take an ever larger share of GDP. Scientific progress, augmented intelligence and a more empowered patient are driving changes in the delivery of health care to a personalized experience that demands health outcomes as the core metric. This is causing a power shift among traditional stakeholder groups, with new entrants (often not driven by profit) disrupting incumbents. Innovation, productivity and access to patients remain the industry’s biggest challenges. These trends challenge the capital strategy of every link in the life sciences value chain, from R&D and product supply to product launch and patient-centric operating models. Our Global Life Sciences Sector brings together a worldwide network of 11,000 sector-focused professionals to anticipate trends, identify their implications and help our clients create competitive advantage. We can help you navigate your way forward and achieve sustainable success in the new health-outcomes-driven ecosystem. Biotechnology Pharmaceutical Medical technology Contact us Contact a member of our global team. Connect with us Stay connected with us through social media, email alerts or webcasts. Or download our EY Insights app for mobile devices. EY Health & Life Sciences Webcast Trump’s first 100 days: health and life sciences. Does your best market opportunity come from another market? Executives from different industries are gathering at the EY Convergence Lab in San Francisco on 26 April. Come help create the future of your industry. Navigating Brexit in life sciences Life sciences companies weighing their options have a number of opportunities and risks to consider. EY_LifeSciences Privacy Privacy Shield BCR Accessibility Legal Global Code of Conduct Site map Our locations Contact us EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. This site uses cookies to provide you with a personalised browsing experience. By using this site you agree to our use of cookies as explained in our Privacy Policy. Please read our Privacy Policy for more information on how we use cookies and how you can manage them. Close